Trials of two Ebola treatments to start in DRC next week: WHO
The WHO is set to begin clinical trials for two potential Ebola treatments in the Democratic Republic of Congo to combat a rare outbreak. The study will evaluate the effectiveness of monoclonal antibodies and antiviral drugs in reducing mortality.
Why it matters
Addresses a critical public health crisis in a region where no approved treatments currently exist for this specific virus strain.
This article has been reviewed according to Science X's editorial process and policies . Editors have highlighted the following attributes while ensuring the content's credibility:
Objective reporting on medical research and public health initiatives.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in